2 results
Approved WMOCompleted
The primary objective is to evaluate the safety and efficacy of the PulseCath iVAC2L in highriskPCI patients who require left ventricular assistance. Safety will be assessed by theincidence of Cerebrovascular Accidents (CVA*s), thrombo-embolic…
Approved WMOPending
General- To determine the safety of OTL38 in IBD and rheumatoid arthritis patients by monitoring of vital signs during tracer infusion and evaluating possible (severe) adverse events (SAE/AEs).RA- To determine the feasibility of molecular…